The Pharma and Health science segment is on a ‘Global growth mode'. The proliferation of our generics, increased spending on R&D and manufacturing units coming up overseas are all indicators of bigger and better things to come.

At FogHorn it is our vision that Global drug majors will be looking at outsourcing specific parts of their 21CFR Part 11 compliance needs in the near future. The penalty and consent decrees issued by the FDA in the recent past have put a spotlight on the fact that industry does need to comply.

The Foghorn Content services team is preparing a knowledge base so we are able to provide an outsourcing solution as and when the industry looks for outsourcing partners. Unlike a host of other BPO operations, we will focus on creating a virtual think tank of industry experts, make our offerings process oriented and be actual advisors on how to optimize the creation, management and compliance of content.